(+)-catechin multiple interactions ISO SLC18A2 (Homo sapiens) 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of SLC18A2 mRNA CTD PMID:24763279 (R)-noradrenaline multiple interactions EXP 6480464 Norepinephrine inhibits the reaction [SLC18A2 protein results in increased uptake of Serotonin] CTD PMID:1438304 (R)-noradrenaline decreases activity ISO SLC18A2 (Homo sapiens) 6480464 Norepinephrine results in decreased activity of SLC18A2 protein CTD PMID:15475732 (R)-noradrenaline affects binding ISO SLC18A2 (Homo sapiens) 6480464 Norepinephrine binds to SLC18A2 protein CTD PMID:7912402 (S)-amphetamine affects response to substance ISO Slc18a2 (Mus musculus) 6480464 SLC18A2 protein affects the susceptibility to Dextroamphetamine CTD PMID:12716422 (S)-amphetamine affects binding ISO SLC18A2 (Homo sapiens) 6480464 Dextroamphetamine binds to SLC18A2 protein CTD PMID:7912402 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO Slc18a2 (Mus musculus) 6480464 [1-Methyl-4-phenyl-1 more ... CTD PMID:16011487 more ... 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine affects response to substance ISO Slc18a2 (Mus musculus) 6480464 SLC18A2 protein affects the susceptibility to 1-Methyl-4-phenyl-1 more ... CTD PMID:27287315 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine decreases expression ISO Slc18a2 (Mus musculus) 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:16011487 more ... 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine decreases activity ISO Slc18a2 (Mus musculus) 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:16011487 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of SLC18A2 mRNA CTD PMID:16079270 17beta-estradiol multiple interactions ISO Slc18a2 (Mus musculus) 6480464 Estradiol inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:16011487 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Slc18a2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Slc18a2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Slc18a2 (Mus musculus) 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SLC18A2 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC18A2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Slc18a2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC18A2 mRNA CTD PMID:21889950 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc18a2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC18A2 mRNA CTD PMID:26377647 3,4-methylenedioxymethamphetamine increases expression ISO Slc18a2 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of SLC18A2 mRNA CTD PMID:20188158 3,4-methylenedioxymethamphetamine multiple interactions ISO SLC18A2 (Homo sapiens) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine inhibits the reaction [SLC18A2 protein results in increased uptake of Dopamine] CTD PMID:29908239 3,4-methylenedioxymethamphetamine decreases activity EXP 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased activity of SLC18A2 protein CTD PMID:29908239 4,4'-sulfonyldiphenol increases expression ISO Slc18a2 (Mus musculus) 6480464 bisphenol S results in increased expression of SLC18A2 mRNA CTD PMID:30951980 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of SLC18A2 mRNA CTD PMID:24780913 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SLC18A2 mRNA CTD PMID:30047161 9,10-dimethoxy-3-isobutyl-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one decreases activity ISO Slc18a2 (Mus musculus) 6480464 Tetrabenazine results in decreased activity of SLC18A2 protein CTD PMID:19616025 9,10-dimethoxy-3-isobutyl-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one multiple interactions EXP 6480464 Tetrabenazine inhibits the reaction [SLC18A2 protein results in increased uptake of Serotonin] CTD PMID:1438304 9,10-dimethoxy-3-isobutyl-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one affects binding ISO SLC18A2 (Homo sapiens) 6480464 Tetrabenazine binds to SLC18A2 protein CTD PMID:7912402 9,10-dimethoxy-3-isobutyl-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one decreases activity ISO SLC18A2 (Homo sapiens) 6480464 Tetrabenazine results in decreased activity of SLC18A2 protein CTD PMID:15475732 and PMID:33378168 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of SLC18A2 CTD PMID:25943760 aflatoxin B1 increases methylation ISO SLC18A2 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of SLC18A2 intron CTD PMID:30157460 Aflatoxin B2 alpha increases methylation ISO SLC18A2 (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of SLC18A2 intron CTD PMID:30157460 aldehydo-D-glucose multiple interactions ISO Slc18a2 (Mus musculus) 6480464 fucoxanthin inhibits the reaction [Glucose results in decreased expression of SLC18A2 mRNA] CTD PMID:33448797 aldehydo-D-glucose decreases expression ISO Slc18a2 (Mus musculus) 6480464 Glucose results in decreased expression of SLC18A2 mRNA CTD PMID:33448797 alendronic acid affects expression EXP 6480464 Alendronate affects the expression of SLC18A2 mRNA CTD PMID:16079270 amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of SLC18A2 mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC18A2 mRNA CTD PMID:16483693 amphetamine decreases expression ISO Slc18a2 (Mus musculus) 6480464 Amphetamine results in decreased expression of SLC18A2 protein CTD PMID:11731100 amphetamine multiple interactions ISO Slc18a2 (Mus musculus) 6480464 SOD1 protein inhibits the reaction [Amphetamine results in decreased expression of SLC18A2 protein] CTD PMID:11731100 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO SLC18A2 (Homo sapiens) 6480464 pyrazolanthrone inhibits the reaction [Rotenone results in decreased activity of SLC18A2 protein] CTD PMID:25496994 antimycin A increases expression ISO SLC18A2 (Homo sapiens) 6480464 Antimycin A results in increased expression of SLC18A2 mRNA CTD PMID:33512557 arsenite(3-) increases expression ISO Slc18a2 (Mus musculus) 6480464 arsenite results in increased expression of SLC18A2 mRNA CTD PMID:33053406 arsenite(3-) affects expression ISO Slc18a2 (Mus musculus) 6480464 arsenite affects the expression of SLC18A2 mRNA CTD PMID:33053406 Asiaticoside multiple interactions EXP 6480464 asiaticoside inhibits the reaction [Rotenone results in decreased expression of SLC18A2 mRNA] CTD PMID:28238857 atrazine increases expression EXP 6480464 Atrazine results in increased expression of SLC18A2 mRNA CTD PMID:23123945 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of SLC18A2 mRNA and Atrazine results in decreased expression of SLC18A2 protein CTD PMID:24552878 more ... b-Dihydrotetrabenazine affects binding EXP 6480464 SLC18A2 protein binds to dihydrotetrabenazine CTD PMID:18287335 benzo[a]pyrene increases methylation ISO SLC18A2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of SLC18A2 5' UTR and Benzo(a)pyrene results in increased methylation of SLC18A2 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO SLC18A2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SLC18A2 intron CTD PMID:30157460 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC18A2 mRNA CTD PMID:26186136 and PMID:34947998 bisphenol A decreases expression ISO Slc18a2 (Mus musculus) 6480464 bisphenol A results in decreased expression of SLC18A2 mRNA CTD PMID:32156529 bisphenol A multiple interactions ISO SLC18A2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC18A2 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC18A2 mRNA CTD PMID:25181051 bisphenol F increases expression EXP 6480464 4 and 4'-bisphenol F results in increased expression of SLC18A2 mRNA CTD PMID:26186136 calcitriol multiple interactions ISO SLC18A2 (Homo sapiens) 6480464 Calcitriol inhibits the reaction [VDR protein results in increased expression of SLC18A2 mRNA] CTD PMID:27450565 carbamazepine affects expression ISO SLC18A2 (Homo sapiens) 6480464 Carbamazepine affects the expression of SLC18A2 mRNA CTD PMID:25979313 carbonyl cyanide p-trifluoromethoxyphenylhydrazone multiple interactions EXP 6480464 Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone inhibits the reaction [SLC18A2 protein results in increased uptake of Serotonin] CTD PMID:1438304 CGP 52608 multiple interactions ISO SLC18A2 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to SLC18A2 gene] CTD PMID:28238834 chlordecone increases expression ISO Slc18a2 (Mus musculus) 6480464 Chlordecone results in increased expression of SLC18A2 mRNA CTD PMID:33711761 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of SLC18A2 mRNA CTD PMID:17452286 chlorpyrifos affects expression EXP 6480464 Chlorpyrifos affects the expression of SLC18A2 mRNA CTD PMID:18812211 and PMID:18835401 choline multiple interactions ISO Slc18a2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SLC18A2 gene CTD PMID:20938992 clozapine increases expression EXP 6480464 Clozapine results in increased expression of SLC18A2 mRNA and Clozapine results in increased expression of SLC18A2 protein CTD PMID:12007678 cocaine decreases expression ISO SLC18A2 (Homo sapiens) 6480464 Cocaine results in decreased expression of SLC18A2 protein CTD PMID:12505801 cocaine increases expression EXP 6480464 Cocaine results in increased expression of SLC18A2 protein CTD PMID:25100957 cocaine affects response to substance ISO Slc18a2 (Mus musculus) 6480464 SLC18A2 protein affects the susceptibility to Cocaine CTD PMID:12716422 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [sodium arsenite results in decreased expression of SLC18A2 protein] CTD PMID:27966075 cyhalothrin decreases expression EXP 6480464 cyhalothrin results in decreased expression of SLC18A2 protein CTD PMID:28495607 cypermethrin decreases expression EXP 6480464 cypermethrin results in decreased expression of SLC18A2 mRNA CTD PMID:20815782 D-glucose decreases expression ISO Slc18a2 (Mus musculus) 6480464 Glucose results in decreased expression of SLC18A2 mRNA CTD PMID:33448797 D-glucose multiple interactions ISO Slc18a2 (Mus musculus) 6480464 fucoxanthin inhibits the reaction [Glucose results in decreased expression of SLC18A2 mRNA] CTD PMID:33448797 dabigatran multiple interactions EXP 6480464 Dabigatran inhibits the reaction [Rotenone results in decreased expression of SLC18A2 mRNA] CTD PMID:28585189 DDD multiple interactions ISO Slc18a2 (Mus musculus) 6480464 Dichlorodiphenyldichloroethane inhibits the reaction [SLC18A2 protein results in increased uptake of Dopamine] CTD PMID:18533268 DDT multiple interactions ISO Slc18a2 (Mus musculus) 6480464 DDT inhibits the reaction [SLC18A2 protein results in increased uptake of Dopamine] CTD PMID:18533268 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of SLC18A2 mRNA CTD PMID:23640034 dexamethasone increases expression ISO SLC18A2 (Homo sapiens) 6480464 Dexamethasone results in increased expression of SLC18A2 mRNA CTD PMID:12782123 diazinon affects expression EXP 6480464 Diazinon affects the expression of SLC18A2 mRNA CTD PMID:17452286 diazinon decreases expression EXP 6480464 Diazinon results in decreased expression of SLC18A2 mRNA CTD PMID:18812211 and PMID:18835401 dieldrin increases expression ISO Slc18a2 (Mus musculus) 6480464 Dieldrin results in increased expression of SLC18A2 mRNA and Dieldrin results in increased expression of SLC18A2 protein CTD PMID:16809432 dopamine multiple interactions ISO SLC18A2 (Homo sapiens) 6480464 Heptachlor Epoxide inhibits the reaction [SLC18A2 protein results in increased uptake of Dopamine] more ... CTD PMID:10499361 and PMID:29908239 dopamine increases uptake ISO SLC18A2 (Homo sapiens) 6480464 SLC18A2 protein results in increased uptake of Dopamine CTD PMID:29908239 dopamine multiple interactions ISO Slc18a2 (Mus musculus) 6480464 DDT inhibits the reaction [SLC18A2 protein results in increased uptake of Dopamine] more ... CTD PMID:18533268 and PMID:27287315 dopamine increases uptake ISO Slc18a2 (Mus musculus) 6480464 SLC18A2 protein results in increased uptake of Dopamine CTD PMID:18533268 dopamine multiple interactions EXP 6480464 Dopamine inhibits the reaction [SLC18A2 protein results in increased uptake of Serotonin] CTD PMID:1438304 dopamine decreases activity ISO SLC18A2 (Homo sapiens) 6480464 Dopamine results in decreased activity of SLC18A2 protein CTD PMID:15475732 dopamine affects binding ISO SLC18A2 (Homo sapiens) 6480464 Dopamine binds to SLC18A2 protein CTD PMID:7912402 dopamine decreases abundance EXP 6480464 SLC18A2 results in decreased abundance of Dopamine CTD PMID:19409267 dorsomorphin multiple interactions ISO SLC18A2 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 entinostat increases expression ISO SLC18A2 (Homo sapiens) 6480464 entinostat results in increased expression of SLC18A2 mRNA CTD PMID:26272509 and PMID:27188386 entinostat multiple interactions ISO SLC18A2 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC18A2 mRNA CTD PMID:27188386 estrone multiple interactions ISO Slc18a2 (Mus musculus) 6480464 Estrone inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:16011487 folic acid multiple interactions ISO Slc18a2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SLC18A2 gene CTD PMID:20938992 folic acid decreases expression ISO Slc18a2 (Mus musculus) 6480464 Folic Acid results in decreased expression of SLC18A2 mRNA CTD PMID:25006883 and PMID:25629700 formaldehyde decreases expression EXP 6480464 Formaldehyde results in decreased expression of SLC18A2 mRNA CTD PMID:12679049 fucoxanthin multiple interactions ISO Slc18a2 (Mus musculus) 6480464 fucoxanthin inhibits the reaction [Glucose results in decreased expression of SLC18A2 mRNA] CTD PMID:33448797 fulvestrant multiple interactions ISO SLC18A2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC18A2 gene CTD PMID:31601247 ganglioside GM1 increases expression EXP 6480464 G(M1) Ganglioside results in increased expression of SLC18A2 mRNA CTD PMID:14552908 genistein decreases expression ISO Slc18a2 (Mus musculus) 6480464 Genistein results in decreased expression of SLC18A2 mRNA CTD PMID:32186404 geraniol multiple interactions ISO Slc18a2 (Mus musculus) 6480464 geraniol inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:23943375 glucose decreases expression ISO Slc18a2 (Mus musculus) 6480464 Glucose results in decreased expression of SLC18A2 mRNA CTD PMID:33448797 glucose multiple interactions ISO Slc18a2 (Mus musculus) 6480464 fucoxanthin inhibits the reaction [Glucose results in decreased expression of SLC18A2 mRNA] CTD PMID:33448797 haloperidol affects binding ISO SLC18A2 (Homo sapiens) 6480464 Haloperidol binds to SLC18A2 protein CTD PMID:7912402 heptachlor increases expression ISO Slc18a2 (Mus musculus) 6480464 Heptachlor results in increased expression of SLC18A2 mRNA and Heptachlor results in increased expression of SLC18A2 protein CTD PMID:10499361 more ... Heptachlor epoxide multiple interactions ISO SLC18A2 (Homo sapiens) 6480464 Heptachlor Epoxide inhibits the reaction [SLC18A2 protein results in increased uptake of Dopamine] CTD PMID:10499361 herbicide decreases expression EXP 6480464 Herbicides results in decreased expression of SLC18A2 mRNA CTD PMID:23123945 histamine multiple interactions EXP 6480464 Rabeprazole promotes the reaction [SLC18A2 protein results in increased secretion of Histamine] CTD PMID:14642791 histamine affects binding ISO SLC18A2 (Homo sapiens) 6480464 Histamine binds to SLC18A2 protein CTD PMID:7912402 histamine increases secretion EXP 6480464 SLC18A2 protein results in increased secretion of Histamine CTD PMID:14642791 hydroquinone O-beta-D-glucopyranoside decreases expression ISO SLC18A2 (Homo sapiens) 6480464 Arbutin results in decreased expression of SLC18A2 mRNA CTD PMID:17103032 ketoconazole multiple interactions ISO Slc18a2 (Mus musculus) 6480464 Ketoconazole inhibits the reaction [Maneb results in decreased expression of SLC18A2 protein] and Ketoconazole inhibits the reaction [Paraquat results in decreased expression of SLC18A2 protein] CTD PMID:22334051 L-methionine multiple interactions ISO Slc18a2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SLC18A2 gene CTD PMID:20938992 lead diacetate decreases expression ISO Slc18a2 (Mus musculus) 6480464 lead acetate results in decreased expression of SLC18A2 mRNA CTD PMID:22613225 leflunomide decreases expression ISO SLC18A2 (Homo sapiens) 6480464 leflunomide results in decreased expression of SLC18A2 mRNA CTD PMID:28988120 maneb multiple interactions ISO Slc18a2 (Mus musculus) 6480464 [Paraquat co-treated with Maneb] results in decreased expression of SLC18A2 mRNA more ... CTD PMID:18386188 more ... maneb decreases expression ISO Slc18a2 (Mus musculus) 6480464 Maneb results in decreased expression of SLC18A2 protein CTD PMID:22334051 manganese atom decreases expression EXP 6480464 Manganese results in decreased expression of SLC18A2 mRNA CTD PMID:20224926 manganese(0) decreases expression EXP 6480464 Manganese results in decreased expression of SLC18A2 mRNA CTD PMID:20224926 Mazindol affects binding ISO SLC18A2 (Homo sapiens) 6480464 Mazindol binds to SLC18A2 protein CTD PMID:7912402 melatonin multiple interactions ISO Slc18a2 (Mus musculus) 6480464 Melatonin inhibits the reaction [[Paraquat co-treated with Maneb] results in decreased expression of SLC18A2 mRNA] CTD PMID:20964710 mercury atom decreases expression ISO Slc18a2 (Mus musculus) 6480464 Mercury analog results in decreased expression of SLC18A2 mRNA CTD PMID:25056781 mercury dibromide decreases expression ISO SLC18A2 (Homo sapiens) 6480464 mercuric bromide results in decreased expression of SLC18A2 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO SLC18A2 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC18A2 mRNA CTD PMID:27188386 mercury(0) decreases expression ISO Slc18a2 (Mus musculus) 6480464 Mercury analog results in decreased expression of SLC18A2 mRNA CTD PMID:25056781 methamphetamine decreases expression ISO SLC18A2 (Homo sapiens) 6480464 Methamphetamine results in decreased expression of SLC18A2 protein CTD PMID:16518646 and PMID:16622715 methamphetamine decreases activity ISO SLC18A2 (Homo sapiens) 6480464 Methamphetamine results in decreased activity of SLC18A2 protein CTD PMID:33378168 methamphetamine multiple interactions ISO Slc18a2 (Mus musculus) 6480464 [rottlerin results in decreased activity of PRKCD protein] inhibits the reaction [Methamphetamine results in decreased expression of SLC18A2 protein] and PRKCD protein affects the reaction [Methamphetamine results in decreased expression of SLC18A2 protein] CTD PMID:22512859 methamphetamine decreases expression ISO Slc18a2 (Mus musculus) 6480464 Methamphetamine results in decreased expression of SLC18A2 protein CTD PMID:22512859 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of SLC18A2 protein CTD PMID:17683483 and PMID:17686046 methamphetamine decreases activity EXP 6480464 Methamphetamine results in decreased activity of SLC18A2 protein CTD PMID:17683483 and PMID:19326567 methamphetamine multiple interactions EXP 6480464 S-methylthiocitrulline inhibits the reaction [Methamphetamine results in decreased activity of SLC18A2 protein] and S-methylthiocitrulline inhibits the reaction [Methamphetamine results in decreased expression of SLC18A2 protein] CTD PMID:17683483 methamphetamine increases nitrosation EXP 6480464 Methamphetamine results in increased nitrosation of SLC18A2 protein CTD PMID:17683483 methamphetamine affects localization EXP 6480464 Methamphetamine affects the localization of SLC18A2 protein CTD PMID:17683483 methamphetamine decreases response to substance ISO Slc18a2 (Mus musculus) 6480464 SLC18A2 protein results in decreased susceptibility to Methamphetamine CTD PMID:18643795 methamphetamine affects response to substance ISO Slc18a2 (Mus musculus) 6480464 SLC18A2 protein affects the susceptibility to Methamphetamine CTD PMID:12050851 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of SLC18A2 mRNA CTD PMID:30047161 methoxychlor decreases expression ISO Slc18a2 (Mus musculus) 6480464 Methoxychlor results in decreased expression of SLC18A2 protein CTD PMID:19459224 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of SLC18A2 gene CTD PMID:35440735 methylphenidate decreases expression ISO Slc18a2 (Mus musculus) 6480464 Methylphenidate results in decreased expression of SLC18A2 mRNA CTD PMID:22470460 methylphenidate decreases activity ISO SLC18A2 (Homo sapiens) 6480464 Methylphenidate results in decreased activity of SLC18A2 protein CTD PMID:33378168 N-methyl-4-phenylpyridinium decreases response to substance EXP 6480464 SLC18A2 protein results in decreased susceptibility to 1-Methyl-4-phenylpyridinium CTD PMID:18287335 N-methyl-4-phenylpyridinium increases expression ISO Slc18a2 (Mus musculus) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC18A2 mRNA CTD PMID:26558463 nomifensine affects binding ISO SLC18A2 (Homo sapiens) 6480464 Nomifensine binds to SLC18A2 protein CTD PMID:7912402 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SLC18A2 mRNA CTD PMID:25729387 oxidopamine decreases expression ISO Slc18a2 (Mus musculus) 6480464 Oxidopamine results in decreased expression of SLC18A2 mRNA CTD PMID:17803225 oxidopamine multiple interactions EXP 6480464 Resveratrol inhibits the reaction [Oxidopamine results in decreased expression of SLC18A2 protein] CTD PMID:34302886 oxidopamine decreases expression EXP 6480464 Oxidopamine results in decreased expression of SLC18A2 protein CTD PMID:34302886 paracetamol increases expression ISO SLC18A2 (Homo sapiens) 6480464 Acetaminophen results in increased expression of SLC18A2 mRNA CTD PMID:26690555 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC18A2 mRNA CTD PMID:33387578 paraquat decreases expression ISO Slc18a2 (Mus musculus) 6480464 Paraquat results in decreased expression of SLC18A2 protein CTD PMID:22334051 paraquat decreases activity ISO SLC18A2 (Homo sapiens) 6480464 Paraquat results in decreased activity of SLC18A2 protein CTD PMID:33378168 paraquat multiple interactions EXP 6480464 Paraquat promotes the reaction [Zinc results in decreased expression of SLC18A2 protein] more ... CTD PMID:20553223 and PMID:32060784 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of SLC18A2 mRNA and Paraquat results in decreased expression of SLC18A2 protein CTD PMID:20553223 and PMID:32060784 paraquat multiple interactions ISO Slc18a2 (Mus musculus) 6480464 [Paraquat co-treated with Maneb] results in decreased expression of SLC18A2 mRNA more ... CTD PMID:18386188 more ... PCB138 multiple interactions ISO Slc18a2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 phenylmercury acetate decreases expression ISO SLC18A2 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of SLC18A2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO SLC18A2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC18A2 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO Slc18a2 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC18A2 mRNA CTD PMID:19710929 probenecid multiple interactions ISO Slc18a2 (Mus musculus) 6480464 [1-Methyl-4-phenyl-1 more ... CTD PMID:19653878 pyrroloquinoline quinone multiple interactions EXP 6480464 PQQ Cofactor inhibits the reaction [Rotenone results in decreased expression of SLC18A2 protein] CTD PMID:26276080 quinpirole affects response to substance ISO Slc18a2 (Mus musculus) 6480464 SLC18A2 protein affects the susceptibility to Quinpirole CTD PMID:12716422 rabeprazole multiple interactions EXP 6480464 Rabeprazole promotes the reaction [SLC18A2 protein results in increased secretion of Histamine] CTD PMID:14642791 raloxifene affects expression EXP 6480464 Raloxifene Hydrochloride affects the expression of SLC18A2 mRNA CTD PMID:16079270 reserpine affects binding ISO SLC18A2 (Homo sapiens) 6480464 Reserpine binds to SLC18A2 protein CTD PMID:7912402 reserpine multiple interactions ISO SLC18A2 (Homo sapiens) 6480464 Reserpine inhibits the reaction [SLC18A2 protein results in increased uptake of Dopamine] CTD PMID:29908239 reserpine decreases activity EXP 6480464 Reserpine results in decreased activity of SLC18A2 protein CTD PMID:29908239 reserpine affects binding EXP 6480464 SLC18A2 protein binds to Reserpine CTD PMID:9038139 reserpine increases expression EXP 6480464 Reserpine results in increased expression of SLC18A2 mRNA CTD PMID:8189248 reserpine affects response to substance ISO Slc18a2 (Mus musculus) 6480464 SLC18A2 affects the susceptibility to Reserpine CTD PMID:17664021 reserpine multiple interactions EXP 6480464 Reserpine inhibits the reaction [SLC18A2 protein results in increased uptake of Serotonin] and Serotonin inhibits the reaction [SLC18A2 protein binds to Reserpine] CTD PMID:1438304 more ... reserpine decreases activity ISO SLC18A2 (Homo sapiens) 6480464 Reserpine results in decreased activity of SLC18A2 protein CTD PMID:15475732 and PMID:33378168 reserpine decreases response to substance ISO SLC18A2 (Homo sapiens) 6480464 SLC18A2 gene SNP results in decreased susceptibility to Reserpine CTD PMID:15475732 resveratrol multiple interactions EXP 6480464 Resveratrol inhibits the reaction [Oxidopamine results in decreased expression of SLC18A2 protein] CTD PMID:34302886 rotenone multiple interactions ISO SLC18A2 (Homo sapiens) 6480464 pyrazolanthrone inhibits the reaction [Rotenone results in decreased activity of SLC18A2 protein] CTD PMID:25496994 rotenone multiple interactions EXP 6480464 asiaticoside inhibits the reaction [Rotenone results in decreased expression of SLC18A2 mRNA] more ... CTD PMID:26276080 more ... rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of SLC18A2 mRNA and Rotenone results in decreased expression of SLC18A2 protein CTD PMID:18579341 more ... rotenone decreases activity ISO SLC18A2 (Homo sapiens) 6480464 Rotenone results in decreased activity of SLC18A2 protein CTD PMID:25496994 rottlerin multiple interactions ISO Slc18a2 (Mus musculus) 6480464 [rottlerin results in decreased activity of PRKCD protein] inhibits the reaction [Methamphetamine results in decreased expression of SLC18A2 protein] CTD PMID:22512859 S-methyl-L-thiocitrulline multiple interactions EXP 6480464 S-methylthiocitrulline inhibits the reaction [Methamphetamine results in decreased activity of SLC18A2 protein] and S-methylthiocitrulline inhibits the reaction [Methamphetamine results in decreased expression of SLC18A2 protein] CTD PMID:17683483 SB 431542 multiple interactions ISO SLC18A2 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 SCH 23390 multiple interactions ISO Slc18a2 (Mus musculus) 6480464 SCH 23390 inhibits the reaction [1-(2-thienyl)-2-(methylamino)propane results in decreased expression of SLC18A2 protein] CTD PMID:30922767 serotonin affects binding EXP 5130957 Serotonin binds to Slc8a2 protein RGD serotonin affects binding EXP 6480464 SLC18A2 protein binds to Serotonin CTD PMID:9038139 serotonin increases uptake EXP 6480464 SLC18A2 protein results in increased uptake of Serotonin CTD PMID:1438304 and PMID:18287335 serotonin increases transport EXP 6480464 SLC18A2 protein results in increased transport of Serotonin CTD PMID:9038139 serotonin multiple interactions EXP 6480464 Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone inhibits the reaction [SLC18A2 protein results in increased uptake of Serotonin] more ... CTD PMID:1438304 more ... serotonin affects uptake ISO SLC18A2 (Homo sapiens) 6480464 SLC18A2 gene SNP affects the uptake of Serotonin CTD PMID:15475732 serotonin affects binding ISO SLC18A2 (Homo sapiens) 6480464 Serotonin binds to SLC18A2 protein CTD PMID:7912402 silver atom decreases expression ISO Slc18a2 (Mus musculus) 6480464 Silver results in decreased expression of SLC18A2 mRNA CTD PMID:27131904 silver(0) decreases expression ISO Slc18a2 (Mus musculus) 6480464 Silver results in decreased expression of SLC18A2 mRNA CTD PMID:27131904 simazine affects expression ISO Slc18a2 (Mus musculus) 6480464 Simazine affects the expression of SLC18A2 mRNA and Simazine affects the expression of SLC18A2 protein CTD PMID:29137186 simazine decreases expression EXP 6480464 Simazine results in decreased expression of SLC18A2 mRNA and Simazine results in decreased expression of SLC18A2 protein CTD PMID:29115391 sodium arsenite multiple interactions ISO Slc18a2 (Mus musculus) 6480464 [sodium arsenite affects the localization of NR4A2 protein] inhibits the reaction [NR4A2 protein results in increased expression of SLC18A2 mRNA] CTD PMID:23283970 sodium arsenite increases expression ISO Slc18a2 (Mus musculus) 6480464 sodium arsenite results in increased expression of SLC18A2 mRNA CTD PMID:37682722 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of SLC18A2 protein CTD PMID:27966075 sodium arsenite multiple interactions EXP 6480464 Curcumin inhibits the reaction [sodium arsenite results in decreased expression of SLC18A2 protein] CTD PMID:27966075 sodium arsenite decreases expression ISO Slc18a2 (Mus musculus) 6480464 sodium arsenite results in decreased expression of SLC18A2 mRNA CTD PMID:23283970 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of SLC18A2 mRNA CTD PMID:30047161 sulpiride multiple interactions ISO Slc18a2 (Mus musculus) 6480464 Sulpiride inhibits the reaction [1-(2-thienyl)-2-(methylamino)propane results in decreased expression of SLC18A2 protein] CTD PMID:30922767 telmisartan multiple interactions ISO Slc18a2 (Mus musculus) 6480464 telmisartan inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:23747572 tetrabenazine affects binding ISO SLC18A2 (Homo sapiens) 6480464 Tetrabenazine binds to SLC18A2 protein CTD PMID:7912402 tetrabenazine affects binding EXP 5130957 Tetrabenazine binds to Slc8a2 protein RGD tetrabenazine decreases activity ISO Slc18a2 (Mus musculus) 6480464 Tetrabenazine results in decreased activity of SLC18A2 protein CTD PMID:19616025 tetrabenazine multiple interactions EXP 6480464 Tetrabenazine inhibits the reaction [SLC18A2 protein results in increased uptake of Serotonin] CTD PMID:1438304 tetrabenazine decreases activity ISO SLC18A2 (Homo sapiens) 6480464 Tetrabenazine results in decreased activity of SLC18A2 protein CTD PMID:15475732 and PMID:33378168 topotecan increases expression EXP 6480464 Topotecan results in increased expression of SLC18A2 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SLC18A2 mRNA CTD PMID:25729387 tributylstannane multiple interactions EXP 6480464 tributyltin inhibits the reaction [SLC18A2 protein results in increased uptake of Serotonin] CTD PMID:1438304 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of SLC18A2 mRNA CTD PMID:33387578 trichostatin A increases expression ISO SLC18A2 (Homo sapiens) 6480464 trichostatin A results in increased expression of SLC18A2 mRNA CTD PMID:24935251 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of SLC18A2 mRNA CTD PMID:33078273 trovafloxacin decreases expression ISO Slc18a2 (Mus musculus) 6480464 trovafloxacin results in decreased expression of SLC18A2 mRNA CTD PMID:35537566 valinomycin multiple interactions EXP 6480464 Valinomycin promotes the reaction [SLC18A2 protein results in increased uptake of Serotonin] CTD PMID:18287335 valproic acid decreases methylation ISO SLC18A2 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of SLC18A2 gene CTD PMID:29154799 valproic acid multiple interactions ISO SLC18A2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC18A2 mRNA CTD PMID:27188386 valproic acid increases expression ISO SLC18A2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of SLC18A2 mRNA CTD PMID:24383497 more ... valproic acid affects expression ISO SLC18A2 (Homo sapiens) 6480464 Valproic Acid affects the expression of SLC18A2 mRNA CTD PMID:25979313 vanoxerine dihydrochloride affects binding ISO SLC18A2 (Homo sapiens) 6480464 vanoxerine binds to SLC18A2 protein CTD PMID:7912402 zinc atom decreases expression EXP 6480464 Zinc results in decreased expression of SLC18A2 protein CTD PMID:32060784 zinc atom multiple interactions EXP 6480464 Paraquat promotes the reaction [Zinc results in decreased expression of SLC18A2 protein] and Zinc promotes the reaction [Paraquat results in decreased expression of SLC18A2 protein] CTD PMID:32060784 zinc sulfate multiple interactions EXP 6480464 Paraquat promotes the reaction [Zinc Sulfate results in decreased expression of SLC18A2 mRNA] more ... CTD PMID:20553223 zinc sulfate decreases expression EXP 6480464 Zinc Sulfate results in decreased expression of SLC18A2 mRNA and Zinc Sulfate results in decreased expression of SLC18A2 protein CTD PMID:20553223 zinc(0) multiple interactions EXP 6480464 Paraquat promotes the reaction [Zinc results in decreased expression of SLC18A2 protein] and Zinc promotes the reaction [Paraquat results in decreased expression of SLC18A2 protein] CTD PMID:32060784 zinc(0) decreases expression EXP 6480464 Zinc results in decreased expression of SLC18A2 protein CTD PMID:32060784